PCSK9 and atherosclerosis: In addition to diagnosis role, in terms of therapeutics in the atherosclerosis field, the most successful RNA drugs in atherosclerosis are proprotein convertase subtilsin/kexin type 9 (PCSK9) inhibitors, a siRNA drug that targets PCSK9 mRNA (128).